Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Opinion Editor's Corner

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

Shelley Wood

December 27, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

Presentation TCT 2021

Establishing Consensus: US Guidance Updates

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Presenter: Victor Zeijen

November 04, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Presenter: Michael Bloch

November 04, 2021

Presentation TCT 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presenter: Herbert D. Aronow

November 04, 2021

Presentation TCT 2021

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

News Daily News

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Caitlin E. Cox

October 13, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

Advertisement

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

British Medical Groups Express Concern About Inclisiran Rollout

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

December 2021 News Roundup

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

Establishing Consensus: US Guidance Updates

Leading with Evidence: Latest Data on Renal Denervation

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

FDA Issues New Guidance on Sodium Targets for Food Industry

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content